Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):828–834. doi: 10.1128/aac.33.6.828

Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth.

M Hasobe 1, J G McKee 1, R T Borchardt 1
PMCID: PMC284240  PMID: 2764532

Abstract

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine (compound 1) and -3-deazaadenine (compound 2), which are specific inhibitors of S-adenosylhomocysteine (AdoHcy) hydrolase, were reported earlier by our laboratory (M. Hasobe, J. G. McKee, D. R. Borcherding, and R. T. Borchardt, Antimicrob. Agents Chemother. 31:1849-1851, 1987) to have anti-vaccinia virus activity with reduced murine L-929 cell toxicity compared with the prototype compound neplanocin A. In this study, we showed that the antiviral and cytotoxic effects of compounds 1 and 2 can be related to intracellular concentrations of AdoHey, which are elevated in cells treated with these inhibitors of AdoHcy hydrolase. For example, concentrations of analogs 1 and 2 that produce 50% inhibition of vaccinia virus replication caused only slight elevations in intracellular levels of AdoHcy (from 50 [controls] to 100 to 125 [drug-treated cells] pmol/mg of protein) and elevations in the ratios of AdoHcy/S-adenosylmethionine (from 0.05 to 0.1 [controls] to 0.15 to 0.19 [drug-treated cells]). In contrast to the extreme susceptibility of virus replication to slight elevations in intracellular AdoHcy, cell viability was quite tolerant to higher levels of this metabolite. For example, concentrations of analogs 1 and 2 that produced 50% inhibition of L-929 cell replication caused significant increases in intracellular levels of AdoHcy (to 825 to 950 pmol/mg of protein) and elevations in AdoHcy/S-adenosylmethionine ratios (approximately 1.3). These data make it possible to assign a therapeutic index of 7 to 8 to these compounds on the basis of the comparison of intracellular levels of AdoHcy that caused 50% inhibition of vaccinia virus replication with those that caused 50% inhibition of L-929 cell replication.

Full text

PDF
828

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee A. K. 5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev. 1980 Jun;44(2):175–205. doi: 10.1128/mr.44.2.175-205.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartel R. L., Borchardt R. T. Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells. Mol Pharmacol. 1984 May;25(3):418–424. [PubMed] [Google Scholar]
  3. Borchardt R. T., Keller B. T., Patel-Thombre U. Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J Biol Chem. 1984 Apr 10;259(7):4353–4358. [PubMed] [Google Scholar]
  4. Bouloy M., Plotch S. J., Krug R. M. Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3952–3956. doi: 10.1073/pnas.77.7.3952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother. 1985 Jul;28(1):84–89. doi: 10.1128/aac.28.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Clercq E., Cools M. Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase. Biochem Biophys Res Commun. 1985 May 31;129(1):306–311. doi: 10.1016/0006-291x(85)91438-x. [DOI] [PubMed] [Google Scholar]
  7. De Clercq E. S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem Pharmacol. 1987 Aug 15;36(16):2567–2575. doi: 10.1016/0006-2952(87)90533-8. [DOI] [PubMed] [Google Scholar]
  8. Glazer R. I., Hartman K. D., Knode M. C., Richard M. M., Chiang P. K., Tseng C. K., Marquez V. E. 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Commun. 1986 Mar 13;135(2):688–694. doi: 10.1016/0006-291x(86)90048-3. [DOI] [PubMed] [Google Scholar]
  9. Glazer R. I., Knode M. C. Neplanocin A. A cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation. J Biol Chem. 1984 Nov 10;259(21):12964–12969. [PubMed] [Google Scholar]
  10. Glazer R. I., Knode M. C., Tseng C. K., Haines D. R., Marquez V. E. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem Pharmacol. 1986 Dec 15;35(24):4523–4527. doi: 10.1016/0006-2952(86)90774-4. [DOI] [PubMed] [Google Scholar]
  11. Hasobe M., McKee J. G., Borcherding D. R., Borchardt R. T. 9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob Agents Chemother. 1987 Nov;31(11):1849–1851. doi: 10.1128/aac.31.11.1849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hasobe M., Mckee J. G., Borcherding D. R., Keller B. T., Borchardt R. T. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells. Mol Pharmacol. 1988 Jun;33(6):713–720. [PubMed] [Google Scholar]
  13. Hoshi A., Yoshida M., Iigo M., Tokuzen R., Fukukawa K., Ueda T. Antitumor activity of derivatives of neplanocin A in vivo and in vitro. J Pharmacobiodyn. 1986 Feb;9(2):202–206. doi: 10.1248/bpb1978.9.202. [DOI] [PubMed] [Google Scholar]
  14. Inaba M., Nagashima K., Tsukagoshi S., Sakurai Y. Biochemical mode of cytotoxic action of neplanocin A in L1210 leukemic cells. Cancer Res. 1986 Mar;46(3):1063–1067. [PubMed] [Google Scholar]
  15. Keller B. T., Borchardt R. T. Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells. Mol Pharmacol. 1987 May;31(5):485–492. [PubMed] [Google Scholar]
  16. Keller B. T., Borchardt R. T. Metabolic conversion of neplanocin A to S-neplanocylmethionine by mouse L 929 cells. Biochem Biophys Res Commun. 1984 Apr 16;120(1):131–137. doi: 10.1016/0006-291x(84)91423-2. [DOI] [PubMed] [Google Scholar]
  17. Keller B. T., Clark R. S., Pegg A. E., Borchardt R. T. Purification and characterization of some metabolic effects of S-neplanocylmethionine. Mol Pharmacol. 1985 Oct;28(4):364–370. [PubMed] [Google Scholar]
  18. Linevsky J., Cohen M. B., Hartman K. D., Knode M. C., Glazer R. I. Effect of neplanocin A on differentiation, nucleic acid methylation, and c-myc mRNA expression in human promyelocytic leukemia cells. Mol Pharmacol. 1985 Jul;28(1):45–50. [PubMed] [Google Scholar]
  19. Matuszewska B., Borchardt R. T. The role of nicotinamide adenine dinucleotide in the inhibition of bovine liver S-adenosylhomocysteine hydrolase by neplanocin A. J Biol Chem. 1987 Jan 5;262(1):265–268. [PubMed] [Google Scholar]
  20. Montgomery J. A., Clayton S. J., Thomas H. J., Shannon W. M., Arnett G., Bodner A. J., Kion I. K., Cantoni G. L., Chiang P. K. Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target. J Med Chem. 1982 Jun;25(6):626–629. doi: 10.1021/jm00348a004. [DOI] [PubMed] [Google Scholar]
  21. Narayanan S. R., Keller B. T., Borcherding D. R., Scholtz S. A., Borchardt R. T. 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl) derivatives of adenine and 3-deazaadenine: potent inhibitors of bovine liver S-adenosylhomocysteine hydrolase. J Med Chem. 1988 Mar;31(3):500–503. doi: 10.1021/jm00398a002. [DOI] [PubMed] [Google Scholar]
  22. Plotch S. J., Tomasz J., Krug R. M. Absence of detectable capping and methylating enzymes in influenza virions. J Virol. 1978 Oct;28(1):75–83. doi: 10.1128/jvi.28.1.75-83.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ransohoff R. M., Narayan P., Ayers D. F., Rottman F. M., Nilsen T. W. Priming of influenza mRNA transcription is inhibited in CHO cells treated with the methylation inhibitor, neplanocin A. Antiviral Res. 1987 Jul;7(6):317–327. doi: 10.1016/0166-3542(87)90014-3. [DOI] [PubMed] [Google Scholar]
  24. Saunders P. P., Tan M. T., Robins R. K. Metabolism and action of neplanocin A in Chinese hamster ovary cells. Biochem Pharmacol. 1985 Aug 1;34(15):2749–2754. doi: 10.1016/0006-2952(85)90576-3. [DOI] [PubMed] [Google Scholar]
  25. Tanaka K., Yoshioka A., Tanaka S., Wataya Y. An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 1984 May 15;139(1):35–41. doi: 10.1016/0003-2697(84)90386-5. [DOI] [PubMed] [Google Scholar]
  26. Ueland P. M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev. 1982 Sep;34(3):223–253. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES